Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy

Kibeom Kim,Myoung-Hwan Park
DOI: https://doi.org/10.3390/biomedicines12010202
IF: 4.757
2024-01-17
Biomedicines
Abstract:Peptide-functionalized nanomedicine, which addresses the challenges of specificity and efficacy in drug delivery, is emerging as a pivotal approach for cancer therapy. Globally, cancer remains a leading cause of mortality, and conventional treatments, such as chemotherapy, often lack precision and cause adverse effects. The integration of peptides into nanomedicine offers a promising solution for enhancing the targeting and delivery of therapeutic agents. This review focuses on the three primary applications of peptides: cancer cell-targeting ligands, building blocks for self-assembling nanostructures, and elements of stimuli-responsive systems. Nanoparticles modified with peptides improved targeting of cancer cells, minimized damage to healthy tissues, and optimized drug delivery. The versatility of self-assembled peptide structures makes them an innovative vehicle for drug delivery by leveraging their biocompatibility and diverse nanoarchitectures. In particular, the mechanism of cell death induced by self-assembled structures offers a novel approach to cancer therapy. In addition, peptides in stimuli-responsive systems enable precise drug release in response to specific conditions in the tumor microenvironment. The use of peptides in nanomedicine not only augments the efficacy and safety of cancer treatments but also suggests new research directions. In this review, we introduce systems and functionalization methods using peptides or peptide-modified nanoparticles to overcome challenges in the treatment of specific cancers, including breast cancer, lung cancer, colon cancer, prostate cancer, pancreatic cancer, liver cancer, skin cancer, glioma, osteosarcoma, and cervical cancer.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?
The main problems that this paper attempts to solve are the specificity and efficacy issues in cancer treatment. Specifically, the author focuses on how to improve the targeting and effectiveness of drug delivery through peptide - functionalized nanomedicine, thereby effectively treating cancer. Traditional cancer treatment methods such as chemotherapy can treat cancer to a certain extent, but often lack precision and may cause side effects. By integrating peptides into nanomedicine, a promising solution can be provided to enhance the targeting and delivery efficiency of therapeutic agents. The paper mainly explores three main applications of peptides in nanomedicine: 1. **Cancer cell - targeting ligands**: By modifying peptides on the surface of nanoparticles, the targeting ability to cancer cells can be improved, damage to healthy tissues can be reduced, and drug delivery can be optimized. 2. **Building blocks for self - assembling nanostructures**: The self - assembling properties of peptides make them innovative drug - delivery carriers, taking advantage of their biocompatibility and diverse nanostructures. 3. **Elements of stimuli - responsive systems**: The application of peptides in stimuli - responsive systems enables drugs to be precisely released under specific conditions in the tumor microenvironment. Through these methods, the application of peptides in nanomedicine not only enhances the effectiveness and safety of cancer treatment but also provides inspiration for new research directions. The paper specifically introduces the use of peptides or peptide - modified nanoparticles to overcome the challenges in the treatment of specific cancers (including breast cancer, lung cancer, colon cancer, prostate cancer, pancreatic cancer, liver cancer, skin cancer, glioma, osteosarcoma, and cervical cancer) and describes the methods of peptide functionalization.